Paper

The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.

Published Mar 1, 2023 · L. Setayesh, Neda Haghighat, Niloufar Rasaei

Diabetes & metabolic syndrome

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Meta-Analysis

Study Snapshot

Amla supplementation shows promise for improving metabolic parameters in adults, with significant reductions in CRP, fasting blood glucose, low-density lipoprotein cholesterol, total cholesterol, and serum triglyceride concentrations.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.

References

Citations